This activity is supported by an educational grant from Pfizer, Inc.
Expiration Date: 12/19/2018
As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will require education about the appropriate incorporation…go to activity»
This activity is supported by independent educational grants from AbbVie, Inc.; Pfizer, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and UCB, Inc.
Expiration Date: 11/26/2018
Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3 million people in the United States. Substantial room…go to activity»
Expiration Date: 6/8/2018
Ulcerative colitis (UC) is an inflammatory bowel disease with a progressive course characterized by exacerbations and remissions. Traditionally, the goals of therapy for…go to activity»
This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.
Expiration Date: 5/15/2018
Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical hallmark of FCS is pancreatitis associated with marked…go to activity»